ORIGINAL ARTICLE
Plasma Homocysteine and Lipoprotein (A) Levels in Patients with Metabolic Syndrome
 
 
More details
Hide details
1
Sütçü İmam University, Faculty of Medicine, Department of Cardiology, Kahramanmaraş, Turkey
 
2
Sütçü İmam University, Faculty of Medicine, Department of Biochemistry, Kahramanmaraş, Turkey
 
 
Online publication date: 2004-04-15
 
 
Publication date: 2004-04-15
 
 
Corresponding author
Aytekin Güven   

Kahramanmaras Sutcu Imam Universitesi Tıp Fakültesi Kardiyoloji AD 46050 Kahramanmaraş–Turkey Phone: +90 344 - 221 23 37 Fax: +90 344 - 221 23 71
 
 
Eur J Gen Med 2004;1(2):38-42
 
KEYWORDS
ABSTRACT
A high serum total homocysteine (tHcy) level is an independent risk factor for cardiovascular disease. In this study, we examined the relationship of tHcy levels with the components of the metabolic syndrome. Fifty one patients diagnosed as metabolic syndrome (median age: 38 (25-48) years) and 50 healthy subjects (median age: 35 (26-48) years) were included in the study. Total homocysteine levels were significantly higher in metabolic syndrome group than in the control group (24.2µmol/l vs. 13.4µmol/l). Vitamin B12 levels were significantly lower in metabolic syndrome group than in the control group (214pg/ml vs. 247pg/ml). In partial correlation, tHcy concentrations were unrelated to metabolic syndrome or to the components of the metabolic syndrome, including fasting serum triglycerides, HDL-cholesterol, fasting glucose, blood pressure, or body mass index. tHcy levels were only strongly related to the vitamin B12 concentrations. The risk of cardiovascular disease is higher in patients with metabolic syndrome compared to the normal population. High tHcy levels might be evaluated in this group of patients in addition to evaluation of the parameters of metabolic syndrome.
eISSN:2516-3507
Journals System - logo
Scroll to top